The actin-associating protein Tm5NM1 blocks mesenchymal motility without transition to amoeboid motility

Oncogene

Volumn 30, Issue 10, 2011, Pages 1241-1251

  Lees, J G ^a   Bach, C T T ^a,b   Bradbury, P ^a   Paul, A ^a   Gunning, P W ^c   O'Neill, G M ^a,b  

^a CHILDREN S HOSPITAL AT WESTMEAD   (Australia)

^b UNIVERSITY OF SYDNEY   (Australia)

^c UNIVERSITY OF NEW SOUTH WALES   (Australia)

Author keywords

actin cytoskeleton; adhesion; amoeboid; mesenchymal; metastasis; tropomyosin

Indexed keywords

COLLAGEN GEL; PROTEIN TM5NM1; PROTEIN TYROSINE KINASE; TROPOMYOSIN; UNCLASSIFIED DRUG;

ANIMAL CELL; ARTICLE; CELL MIGRATION; CELL MOTILITY; CELL STRUCTURE; DOWN REGULATION; ENZYME ACTIVITY; HUMAN; HUMAN CELL; MESENCHYME; NONHUMAN; PRIORITY JOURNAL; PSEUDOPODIUM;

ANIMALS; BLOTTING, WESTERN; CELL LINE, TUMOR; CELL MOVEMENT; HUMANS; MICE; MICROSCOPY, FLUORESCENCE; PSEUDOPODIA; RATS; TROPOMYOSIN;

EID: 79952534369     PISSN: 09509232     EISSN: 14765594     Source Type: Journal    
DOI: 10.1038/onc.2010.516     Document Type: Article

References (36)

1. Bach CT, Creed S, Zhong J, Mahmassani M, Schevzov G, Stehn J et al. (2009). Tropomyosin isoform expression regulates the transition of adhesions to determine cell speed and direction. Mol Cell Biol 29: 1506-1514.
2. Bargon SD, Gunning PW, O'Neill GM. (2005). The Cas family docking protein, HEF1, promotes the formation of neurite-like membrane extensions. Biochim Biophys Acta 1746: 143-154. (Pubitemid 41774289)
3. Blanchoin L, Pollard TD, Hitchcock-DeGregori SE. (2001). Inhibition of the Arp2/3 complex-nucleated actin polymerization and branch formation by tropomyosin. Curr Biol 11: 1300-1304.
4. Bryce NS, Schevzov G, Ferguson V, Percival JM, Lin JJ, Matsumura F et al. (2003). Specification of actin filament function and molecular composition by tropomyosin isoforms. Mol Biol Cell 14: 1002-1016. (Pubitemid 36337448)
5. Carragher NO, Walker SM, Scott Carragher LA, Harris F, Sawyer TK, Brunton VG et al. (2006). Calpain 2 and Src dependence distinguishes mesenchymal and amoeboid modes of tumour cell invasion: a link to integrin function. Oncogene 25: 5726-5740. (Pubitemid 44435250)
6. Coussens LM, Fingleton B, Matrisian LM. (2002). Matrix metallo-proteinase inhibitors and cancer: trials and tribulations. Science 295: 2387-2392. (Pubitemid 34270240)
7. Creed SJ, Bryce N, Naumanen P, Weinberger R, Lappalainen P, Stehn J et al. (2008). Tropomyosin isoforms define distinct microfilament populations with different drug susceptibility. Eur J Cell Biol 87: 709-720.
8. DesMarais V, Ichetovkin I, Condeelis J, Hitchcock-DeGregori SE. (2002). Spatial regulation of actin dynamics: a tropomyosin-free, actin-rich compartment at the leading edge. J Cell Sci 115: 4649-4660. (Pubitemid 36007758)
9. Drappatz J, Norden AD, Wen PY. (2009). Therapeutic strategies for inhibiting invasion in glioblastoma. Expert Rev Neurother 9: 519-534.
10. Eichinger L, Lee SS, Schleicher M. (1999). Dictyostelium as model system for studies of the actin cytoskeleton by molecular genetics. Microsc Res Tech 47: 124-134. (Pubitemid 29519821)
11. Fath T, Agnes Chan YK, Vrhovski B, Clarke H, Curthoys N, Hook J et al. (2010). New aspects of tropomyosin-regulated neuritogenesis revealed by the deletion of Tm5NM1 and 2. Eur J Cell Biol 89: 489-498.
12. Fidler IJ. (2002). Critical determinants of metastasis. Semin Cancer Biol 12: 89-96. (Pubitemid 34680737)
13. Fincham VJ, Frame MC. (1998). The catalytic activity of Src is dispensable for translocation to focal adhesions but controls the turnover of these structures during cell motility. EMBO J 17: 81-92. (Pubitemid 28041050)
14. Friedl P. (2004). Prespecification and plasticity: shifting mechanisms of cell migration. Curr Opin Cell Biol 16: 14-23. (Pubitemid 38368147)
15. Friedl P, Wolf K. (2003). Tumour-cell invasion and migration: diversity and escape mechanisms. Nat Rev Cancer 3: 362-374. (Pubitemid 37328856)
16. Friedl P, Wolf K. (2010). Plasticity of cell migration: a multiscale tuning model. J Exp Med 207: 11-19.
17. Gunning P, O'neill G, Hardeman E. (2008). Tropomyosin-based regulation of the actin cytoskeleton in time and space. 88: 1-35.
18. Gunning PW, Schevzov G, Kee AJ, Hardeman EC. (2005). Tropomyosin isoforms: divining rods for actin cytoskeleton function. Trends Cell Biol 15: 333-341. (Pubitemid 40805330)
19. Gupton SL, Anderson KL, Kole TP, Fischer RS, Ponti A, Hitchcock-DeGregori SE et al. (2005). Cell migration without a lamellipodium: translation of actin dynamics into cell movement mediated by tropomyosin. J Cell Biol 168: 619-631. (Pubitemid 40271027)
20. Hillberg L, Zhao Rathje LS, Nyakern-Meazza M, Helfand B, Goldman RD, Schutt CE et al. (2006). Tropomyosins are present in lamellipodia of motile cells. Eur J Cell Biol 85: 399-409.
21. Ishikawa R, Yamashiro S, Matsumura F. (1989). Differential modulation of actin-severing activity of gelsolin by multiple isoforms of cultured rat cell tropomyosin. Potentiation of protective ability of tropomyosins by 83-kDa nonmuscle caldesmon. J Biol Chem 264: 7490-7497. (Pubitemid 19119165)
22. Kitzing TM, Wang Y, Pertz O, Copeland JW, Grosse R. (2010). Formin-like 2 drives amoeboid invasive cell motility downstream of RhoC. Oncogene 1: 1-8.
23. Kruger A, Soeltl R, Sopov I, Kopitz C, Arlt M, Magdolen V et al. (2001). Hydroxamate-type matrix metalloproteinase inhibitor batimastat promotes liver metastasis. Cancer Res 61: 1272-1275. (Pubitemid 34292540)
24. O'Neill GM. (2009). The coordination between actin filaments and adhesion in mesenchymal migration. Cell Adh Migr 3: 355-357.
25. Percival JM, Hughes JA, Brown DL, Schevzov G, Heimann K, Vrhovski B et al. (2004). Targeting of a tropomyosin isoform to short microfilaments associated with the Golgi complex. Mol Biol Cell 15: 268-280. (Pubitemid 38044962)
26. Poste G, Fidler IJ. (1980). The pathogenesis of cancer metastasis. Nature 283: 139-146. (Pubitemid 10171124)
27. Riedl J, Crevenna AH, Kessenbrock K, Yu JH, Neukirchen D, Bista M et al. (2008). Lifeact: a versatile marker to visualize F-actin. Nat Methods 5: 605-607. (Pubitemid 351911864)
28. Sahai E. (2007). Illuminating the metastatic process. Nat Rev Cancer 7: 737-749. (Pubitemid 47463672)
29. Sahai E, Marshall CJ. (2003). Differing modes of tumour cell invasion have distinct requirements for Rho/ROCK signalling and extracellular proteolysis. Nat Cell Biol 5: 711-719. (Pubitemid 36986778)
30. Sanz-Moreno V, Gadea G, Ahn J, Paterson H, Marra P, Pinner S et al. (2008). Rac activation and inactivation control plasticity of tumor cell movement. Cell 135: 510-523.
31. Schevzov G, Vrhovski B, Bryce NS, Elmir S, Qiu MR, O'Neill GM et al. (2005). Tissue-specific tropomyosin isoform composition. J Histochem Cytochem 53: 557-570. (Pubitemid 40593969)
32. Webb DJ, Donais K, Whitmore LA, Thomas SM, Turner CE, Parsons JT et al. (2004). FAK-Src signalling through paxillin, ERK and MLCK regulates adhesion disassembly. Nat Cell Biol 6: 154-161. (Pubitemid 38425715)
33. Wolf K, Mazo I, Leung H, Engelke K, Von Andrian UH, Deryugina EI et al. (2003). Compensation mechanism in tumor cell migration: mesenchymal-amoeboid transition after blocking of pericellular proteolysis. J Cell Biol 160: 267-277. (Pubitemid 36254960)
34. Wyckoff JB, Pinner SE, Gschmeissner S, Condeelis JS, Sahai E. (2006). ROCK- and myosin-dependent matrix deformation enables protease-independent tumor-cell invasion in vivo. Curr Biol 16: 1515-1523. (Pubitemid 44142977)
35. Yamazaki D, Kurisu S, Takenawa T. (2009). Involvement of Rac and Rho signaling in cancer cell motility in 3D substrates. Oncogene 28: 1570-1583.
36. Zheng Q, Safina A, Bakin AV. (2008). Role of high-molecular weight tropomyosins in TGF-beta-mediated control of cell motility. Int J Cancer 122: 78-90. (Pubitemid 350209981)